the price of The securities after the initial fluctuations in the last three and a half percent to 110,80 euros, with the medical technology group landed on the penultimate place in the MDax for medium-sized values. Carl Zeiss Meditec 110,90 EUR -4,00 (-3,48%) Xetra

• 1 day
• 6 months

To the rate of data

for The full year, the company grow from Jena in sales now, at least on the level of its markets, as it was known at the time of the publication of the Figures for the first quarter. To date, the group was still assumed to grow faster than the market. The operating return on sales should be between 17 and 19 percent and in the medium term, sustained more than 18 percent.

More than 200 percent in the last three years: shareholders were, so far, over a whopping price gains

offers In the first quarter of the Thuringian had surpassed the sales and earnings expectations of analysts easy. Investors, the daughter of the optics and electronics group Carl Zeiss AG are spoiled for some time now, law of success: in 2019, the papers have won almost 70 percent of value added, in the past three years, the price has more than tripled. Before the stock was recently hit in the Wake of the Coronavirus-crisis, she had reached the middle of January set a new record of 122,10 Euro.

Also interesting: Goldman-Sachs-forecast - Lira once again in danger: analysts expect further interest rate cuts in Turkey, Small Caps Champion: The successful in addition to values-based stock market service by Finanzen100. (Partner offer) Now Small Caps Champion for free for 30 days expert test explained: The 70:30 rule explains the best way to protect savers against Inflation, FOCUS Online/Wochit expert: The 70:30 rule is the best way to protect savers against Inflation

hyo/dpa Date Of Update: 10 February 2020, 15:01